FreeTender

This is a dynamic purchasing system or similar standing arrangement, not a one-off tender.

Suppliers can apply to join at any time until 30 November 2028. The buyer then invites admitted suppliers to compete for individual contracts, each with its own short deadline.

Open to joinDynamic purchasing systemGermany

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)

Germany – Pharmaceutical products – Open House Biologika Discount Contracts 2026 - 29 Rituximab (only finished medicines)English, machine translated

Issued by Techniker Krankenkasse · via TED — Tenders Electronic Daily (EU)

Verify & apply on the official portal →
Published
2 Nov 2026
Open to join until
30 Nov 2028, 23:59 UTC
Reference
759317-2026
Location
Germany
Sector
Healthcare & Pharma
Type
goods

At a glance

Techniker Krankenkasse in Germany has published an open-admission purchasing arrangement in healthcare & pharma: “Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)”. Suppliers can apply to join until 30 November 2028. Quote reference 759317-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 79 notices from this buyer since 2026, 57 of them currently open. There are 871 open healthcare & pharma notices in Germany on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.

English summary

Machine translated from German by FreeTender. The original notice below is the binding text.

TK pursues the goal of concluding discount contracts with all suitable pharmaceutical companies in accordance with § 130c para 1 SGB V for the active ingredient rituximab (only finished medicines exclusive dosage form for subcutaneous injection). The contract is concluded within the framework of the Open House procedure of the TK: Individual negotiations on contract contents are not conducted, uniform conditions apply. TK does not guarantee individual contractual partners exclusivity. The term of the contract is a maximum of 24 months starting on 01.12.2026.

Details

Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zu dem Wirkstoff Rituximab (nur Fertigarzneimittel exklusive Darreichungsform zur subkutanen Injektion) zu schließen. Der Vertragsschluss erfolgt im Rahmen des Open-House-Verfahrens der TK: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die TK sichert einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 24 Monate beginnend mit dem 01.12.2026. Der Vertrag endet spätestens am 30.11.2028, unabhängig vom Datum des Vertragsschlusses. Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen.

Lots Lot 1 — Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel): Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zu dem Wirkstoff Rituximab (nur Fertigarzneimittel exklusive Darreichungsform zur subkutanen Injektion) zu schließen.

Buyer: Techniker Krankenkasse

Buyer country: DEU

Procedure: open

CPV code: 33600000

Full notice, tender documents and how to bid are on the official TED page (link above).

Context for bidders

We hold 79 notices from Techniker Krankenkasse, going back to August 2026 — 57 of them still open. They buy mostly in Healthcare & Pharma, IT & Telecom and Construction & Infrastructure. There are 871 open Healthcare & Pharma tenders in Germany. This one closes in 760 days.

Documents

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →